Commission Directive (EU) 2019/1833 of 24 October 2019 amending Annexes I, III, V and VI to Directive 2000/54/EC of the European Parliament and of the Council as regards purely technical adjustments
Modified by
- Commission Directive (EU) 2020/739of 3 June 2020amending Annex III to Directive 2000/54/EC of the European Parliament and of the Council as regards the inclusion of SARS-CoV-2 in the list of biological agents known to infect humans and amending Commission Directive (EU) 2019/1833, 32020L0739, June 4, 2020
1. Work in food production plants. 2. Work in agriculture. 3. Work activities where there is contact with animals and/or products of animal origin. 4. Work in healthcare, including isolation and post-mortem units. 5. Work in clinical, veterinary and diagnostic laboratories, excluding diagnostic microbiological laboratories. 6. Work in refuse disposal plants. 7. Work in sewage purification installations."
A: Possible allergic effects D: List of workers exposed to this biological agent to be kept for more than 10 years after the end of last known exposure T: Toxin production V: Effective vaccine available and registered within the EU
Biological agent | Classification | Notes |
---|---|---|
W | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | T | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | T, V | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
3 | ||
3 | ||
3 | ||
2 | ||
3 | ||
3 | D | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | T | |
2 | T | |
2 | T | |
2 | T, V | |
2 | ||
2 | T, V | |
2 | ||
2 | T | |
2 | T | |
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | T | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | V | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | V | |
2 | ||
2 | ||
2 | ||
3 | V | |
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | ||
3 | V | |
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | V | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | T | |
2 | ||
3 | ||
3 | ||
3 | ||
2 | ||
3 | ||
3 | ||
3 | ||
2 | ||
3 | ||
3 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | V | |
3 | V | |
2 | ||
2 | ||
2 | ||
3 | T | |
2 | ||
2 | ||
2 | ||
2 | T | |
2 | ||
2 | ||
2 | ||
2 | T, V | |
2 | T | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | T, V | |
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 |
Classification | Notes | |
---|---|---|
Bunyavirales (O) | ||
Orthohantavirus (G) | ||
Andes orthohantavirus (Hantavirus species causing Hantavirus Pulmonary Syndrome [HPS]) | 3 | |
Bayou orthohantavirus | 3 | |
Black Creek Canal orthohantavirus | 3 | |
Cano Delgadito orthohantavirus | 3 | |
Choclo orthohantavirus | 3 | |
Dobrava-Belgrade orthohantavirus (Hantavirus species causing Haemorrhagic Fever with Renal Syndrome [HFRS]) | 3 | |
El Moro Canyon orthohantavirus | 3 | |
Hantaan orthohantavirus (Hantavirus species causing Haemorrhagic Fever with Renal Syndrome [HFRS]) | 3 | |
Laguna Negra orthohantavirus | 3 | |
Prospect Hill orthohantavirus | 2 | |
Puumala orthohantavirus (Hantavirus species causing Nephropathia Epidemica [NE]) | 2 | |
Seoul orthohantavirus (Hantavirus species causing Haemorrhagic Fever with Renal Syndrome [HFRS]) | 3 | |
Sin Nombre orthohantavirus (Hantavirus species causing Hantavirus Pulmonary Syndrome [HPS]) | 3 | |
Other hantaviruses known to be pathogenic | 2 | |
Orthonairovirus (G) | ||
Crimean-Congo haemorrhagic fever orthonairovirus | 4 | |
Dugbe orthonairovirus | 2 | |
Hazara orthonairovirus | 2 | |
Nairobi sheep disease orthonairovirus | 2 | |
Other nairoviruses known to be pathogenic | 2 | |
Orthobunyavirus (G) | ||
Bunyamwera orthobunyavirus (Germiston virus) | 2 | |
California encephalitis orthobunyavirus | 2 | |
Oropouche orthobunyavirus | 3 | |
Other orthobunyaviruses known to be pathogenic | 2 | |
Phlebovirus (G) | ||
Bhanja phlebovirus | 2 | |
Punta Toro phlebovirus | 2 | |
Rift Valley fever phl | 3 | |
Sandfly fever Naples phlebovirus (Toscana Virus) | 2 | |
SFTS phlebovirus (Severe Fever with Thrombocytopenia Syndrome-Virus) | 3 | |
Other phleboviruses known to be pathogenic | 2 | |
Herpesvirales (O) | ||
Cytomegalovirus (G) | ||
Human betaherpesvirus 5 (Cytomegalovirus) | 2 | |
Lymphocryptovirus (G) | ||
Human gammaherpesvirus 4 (Epstein-Barr virus) | 2 | |
Rhadinoovirus (G) | ||
Human gammaherpesvirus 8 | 2 | D |
Roseolovirus (G) | ||
Human betaherpesvirus 6A (Human B-lymphotropic virus) | 2 | |
Human betaherpesvirus 6B | 2 | |
Human betaherpesvirus 7 | 2 | |
Simplexvirus (G) | ||
Macacine alphaherpesvirus 1 (Herpesvirus simiae, Herpes B virus) | 3 | |
Human alphaherpesvirus 1 (Human herpesvirus 1, Herpes simplex virus type 1) | 2 | |
Human alphaherpesvirus 2 (Human herpesvirus 2, Herpes simplex virus type 2) | 2 | |
Varicellovirus (G) | ||
Human alphaherpesvirus 3 (Herpesvirus varicella-zoster) | 2 | V |
Mononegavirales (O) | ||
Ebolavirus (G) | 4 | |
Marburgvirus (G) | ||
Marburg marburgvirus | 4 | |
Avulavirus (G) | ||
Newcastle disease virus | 2 | |
Henipavirus (G) | ||
Hendra henipavirus | 4 | |
Nipah henipavirus | 4 | |
Morbillivirus (G) | ||
Measles morbillivirus | 2 | V |
Respirovirus (G) | ||
Human respirovirus 1 (Parainfluenza virus 1) | 2 | |
Human respirovirus 3 (Parainfluenza virus 3) | 2 | |
Rubulavirus (G) | ||
Mumps rubulavirus | 2 | V |
Human rubulavirus 2 (Parainfluenza virus 2) | 2 | |
Human rubulavirus 4 (Parainfluenza virus 4) | 2 | |
Metapneumovirus (G) | ||
Orthopneumovirus (G) | ||
Human orthopneumovirus (Respiratory syncytial virus) | 2 | |
Lyssavirus (G) | ||
Australian bat lyssavirus | 3 | V |
Duvenhage lyssavirus | 3 | V |
European bat lyssavirus 1 | 3 | V |
European bat lyssavirus 2 | 3 | V |
Lagos bat lyssavirus | 3 | |
Mokola lyssavirus | 3 | |
Rabies lyssavirus | 3 | V |
Vesiculovirus (G) | ||
Vesicular stomatitis virus, Alagoas vesiculovirus | 2 | |
Vesicular stomatitis virus, Indiana vesiculovirus | 2 | |
Vesicular stomatitis virus, New Jersey vesiculovirus | 2 | |
Piry vesiculovirus (Piry virus) | 2 | |
Nidovirales (O) | ||
Betacoronavirus (G) | ||
Severe acute respiratory syndrome-related coronavirus (SARS-virus) | 3 | |
Middle East respiratory syndrome coronavirus (MERS-virus) | 3 | |
Other | 2 | |
Picornavirales (O) | ||
Cardiovirus (G) | ||
Saffold virus | 2 | |
Cosavirus (G) | ||
Cosavirus A | 2 | |
Enterovirus (G) | ||
Enterovirus A | 2 | |
Enterovirus B | 2 | |
Enterovirus C | 2 | |
Enterovirus D, Human Enterovirus type 70 (Acute haemorrhagic conjunctivitis virus) | 2 | |
Rhinoviruses | 2 | |
Poliovirus, type 1 and 3 | 2 | V |
Poliovirus, type 2 | 3 | V |
Hepatovirus (G) | ||
Hepatovirus A (Hepatitis A virus, Human Enterovirus type 72) | 2 | V |
Kobuvirus (G) | ||
Aichivirus A (Aichi virus 1) | 2 | |
Parechovirus (G) | ||
Parechoviruses A | 2 | |
Parechoviruses B (Ljungan virus) | 2 | |
Other | 2 | |
Unassigned (O) | ||
2 | ||
2 | ||
Mammarenavirus (G) | ||
Brazilian mammarenavirus | 4 | |
Chapare mammarenavirus | 4 | |
Flexal mammarenavirus | 3 | |
Guanarito mammarenavirus | 4 | |
Junín mammarenavirus | 4 | |
Lassa mammarenavirus | 4 | |
Lujo mammarenavirus | 4 | |
Lymphocytic choriomeningitis mammarenavirus, neurotropic strains | 2 | |
Lymphocytic choriomeningitis mammarenavirus (other strains) | 2 | |
Machupo mammarenavirus | 4 | |
Mobala mammarenavirus | 2 | |
Mopeia mammarenavirus | 2 | |
Tacaribe mammarenavirus | 2 | |
Whitewater Arroyo mammarenavirus | 3 | |
Norovirus (G) | ||
Norovirus (Norwalk virus) | 2 | |
Other | 2 | |
Orthohepadnavirus (G) | ||
Hepatitis B virus | 3 | V, D |
Orthohepevirus (G) | ||
Orthohepevirus A (Hepatitis E virus) | 2 | |
Flavivirus (G) | ||
Dengue virus | 3 | |
Japanese encephalitis virus | 3 | V |
Kyasanur Forest disease virus | 3 | V |
Louping ill virus | 3 | |
Murray Valley encephalitis virus (Australia encephalitis virus) | 3 | |
Omsk haemorrhagic fever virus | 3 | |
Powassan virus | 3 | |
Rocio virus | 3 | |
St. Louis encephalitis virus | 3 | |
Tick-borne encephalitis virus | ||
Absettarov virus | 3 | |
Hanzalova virus | 3 | |
Hypr virus | 3 | |
Kumlinge virus | 3 | |
Negishi virus | 3 | |
Russian spring-summer encephalitis | 3 | V |
Tick-borne encephalitis virus Central European subtype | 3 | V |
Tick-borne encephalitis virus Far Eastern Subtype | 3 | |
Tick-borne encephalitis virus Siberian subtype | 3 | V |
Wesselsbron virus | 3 | |
West Nile fever virus | 3 | |
Yellow fever virus | 3 | V |
Zika virus | 2 | |
Other flaviviruses known to be pathogenic | 2 | |
Hepacivirus (G) | ||
Hepacivirus C (Hepatitis C virus) | 3 | D |
Gammainfluenzavirus (G) | ||
Influenza C virus | 2 | V |
Influenzavirus A (G) | ||
Highly Pathogenic Avian Influenza Viruses HPAIV (H5), e.g. H5N1 | 3 | |
Highly Pathogenic Avian Influenza Viruses HPAIV (H7), e.g. H7N7, H7N9 | 3 | |
Influenza A virus | 2 | V |
Influenza A virus A/New York/1/18 (H1N1) (Spanish flu 1918) | 3 | |
Influenza A virus A/Singapore/1/57 (H2N2) | 3 | |
Low Pathogenic Avian Influenza Virus (LPAI) H7N9 | 3 | |
Influenzavirus B (G) | ||
Influenza B virus | 2 | V |
Thogoto virus (G) | ||
Dhori virus (Tick-borne | 2 | |
Thogoto virus (Tick-borne | 2 | |
2 | D | |
Erythroparvovirus (G) | ||
Primate erythroparvovirus 1 (Human parvovirus, B 19 virus) | 2 | |
Betapolyomavirus (G) | ||
Human polyomavirus 1 (BK virus) | 2 | D |
Human polyomavirus 2 (JC virus) | 2 | D |
Molluscipoxvirus (G) | ||
Molluscum contagiosum virus | 2 | |
Orthopoxvirus (G) | ||
Cowpox virus | 2 | |
Monkeypox virus | 3 | V |
Vaccinia virus (incl. Buffalopox virus | 2 | |
Variola (major and minor) virus | 4 | V |
Parapoxvirus (G) | ||
Orf virus | 2 | |
Pseudocowpox virus (Milkers’ node virus, parapoxvirus bovis) | 2 | |
Yatapoxvirus (G) | ||
Tanapox virus | 2 | |
Yaba monkey tumor virus | 2 | |
Seadornavirus (G) | ||
Banna virus | 2 | |
Coltivirus (G) | 2 | |
Rotavirus | 2 | |
Orbivirus (G) | 2 | |
Deltaretrovirus (G) | ||
Primate T-lymphotropic virus 1 (Human T-cell lymphotropic virus, type 1) | 3 | D |
Primate T-lymphotropic virus 2 (Human T-cell lymphotropic virus, type 2) | 3 | D |
Lentivirus (G) | ||
Human immunodeficiency virus 1 | 3 | D |
Human immunodeficiency virus 2 | 3 | D |
Simian Immunodeficiency Virus (SIV) | 2 | |
Alphavirus (G) | ||
Cabassouvirus | 3 | |
Eastern equine encephalomyelitis virus | 3 | V |
Bebaru virus | 2 | |
Chikungunya virus | 3 | |
Everglades virus | 3 | |
Mayaro virus | 3 | |
Mucambo virus | 3 | |
Ndumu virus | 3 | |
O’nyong-nyong virus | 2 | |
Ross River virus | 2 | |
Semliki Forest virus | 2 | |
Sindbis virus | 2 | |
Tonate virus | 3 | |
Venezuelan equine encephalomyelitis virus | 3 | V |
Western equine encephalomyelitis virus | 3 | V |
Other alphaviruses known to be pathogenic | 2 | |
Rubivirus (G) | ||
Rubella virus | 2 | V |
Deltavirus (G) | ||
Hepatitis delta virus | 2 | V, D |
Biological agent | Classification | Notes |
---|---|---|
Agent of Creutzfeldt-Jakob disease | 3 | D |
Variant Agent of Creutzfeldt-Jakob disease | 3 | D |
Agent of Bovine Spongiform Encephalopathy (BSE) and other related animal TSEs | 3 | D |
Agent of Gerstmann-Sträussler-Scheinker syndrome | 3 | D |
Agent of Kuru | 3 | D |
Agent of Scrapie | 2 |
Biological agent | Classification | Notes |
---|---|---|
2 | ||
2 | ||
2 | ||
2 | ||
2 | A | |
2 | A | |
2 | A | |
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
3 | ||
3 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
2 |
Biological agent | Classification | Notes |
---|---|---|
2 | A | |
2 | A | |
2 | ||
3 | ||
3 | ||
2 | A | |
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
2 | ||
3 | A | |
3 | A | |
2 | A | |
2 | A | |
2 | ||
2 | ||
2 | A | |
2 | ||
2 | ||
3 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | A | |
2 | ||
2 | ||
3 | A | |
3 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | A | |
2 | A | |
2 | A | |
2" |
----------------------
A. Containment measures | B. Containment levels | ||
---|---|---|---|
2 | 3 | 4 | |
Workplace | |||
1. The workplace is to be separated from any other activities in the same building | No | Recommended | Yes |
2. The workplace is to be sealable to permit fumigation | No | Recommended | Yes |
Facilities | |||
3. Infected material including any animal is to be handled in a safety cabinet or isolation or other suitable containment | Where appropriate | Yes, where infection is by airborne route | Yes |
Equipment | |||
4. Input air and extract air to the workplace are to be filtered using (HEPA | No | Yes, on extract air | Yes, on input and extract air |
5. The workplace is to be maintained at an air pressure negative to atmosphere | No | Recommended | Yes |
6. Surfaces impervious to water and easy to clean | Yes, for bench and floor | Yes, for bench, floor and other surfaces determined by risk assessment | Yes, for bench, walls, floor and ceiling |
7. Surfaces resistant to acids, alkalis, solvents, disinfectants | Recommended | Yes | Yes |
System of work | |||
8. Access is to be restricted to nominated workers only | Recommended | Yes | Yes, via airlock |
9. Efficient vector control, for example rodents and insects | Recommended | Yes | Yes |
10. Specified disinfection procedures | Yes | Yes | Yes |
11. Safe storage of a biological agent | Yes | Yes | Yes, secure storage |
12. Personnel should shower before leaving the contained area | No | Recommended | Recommended |
Waste | |||
13. Validated inactivation process for the safe disposal of animal carcases | Recommended | Yes, on or off site | Yes, on site |
Other measures | |||
14. A laboratory is to contain its own equipment | No | Recommended | Yes |
15. An observation window, or, alternative, is to be present, so that occupants can be seen | Recommended | Recommended | Yes" |
----------------------
A. Containment measures | B. Containment levels | ||
---|---|---|---|
2 | 3 | 4 | |
General | |||
1. Viable organisms should be handled in a system which physically separates the process from the environment | Yes | Yes | Yes |
2. Exhaust gases from the closed system should be treated so as to: | Minimise release | Prevent release | Prevent release |
3. Sample collection, addition of materials to a closed system and transfer of viable organisms to another closed system, should be performed so as to: | Minimise release | Prevent release | Prevent release |
4. Bulk culture fluids should not be removed from the closed system unless the viable organisms have been: | Inactivated by validated chemical or physical means | Inactivated by validated chemical or physical means | Inactivated by validated chemical or physical means |
5. Seals should be designed so as to: | Minimise release | Prevent release | Prevent release |
6. The controlled area should be designed to contain spillage of the entire contents of the closed system | No | Recommended | Yes |
7. The controlled area should be sealable to permit fumigation | No | Recommended | Yes |
Facilities | |||
8. Decontamination and washing facilities should be provided for personnel | Yes | Yes | Yes |
Equipment | |||
9. Input air and extract air to the controlled area should be HEPA | No | Recommended | Yes |
10. The controlled area should be maintained at an air pressure negative to atmosphere | No | Recommended | Yes |
11. The controlled area should be adequately ventilated to minimise air contamination | Recommended | Recommended | Yes |
System of work | |||
12. Closed systems | Recommended | Recommended | Yes, and purpose-built |
13. Biohazard signs should be posted | Recommended | Yes | Yes |
14. Access should be restricted to nominated personnel only | Recommended | Yes | Yes, via an airlock |
15. Personnel should shower before leaving the controlled area | No | Recommended | Yes |
16. Personnel should wear protective clothing | Yes, work clothing | Yes | Yes, complete change |
Waste | |||
17. Effluent from sinks and showers should be collected and inactivated before release | No | Recommended | Yes |
18. Effluent treatment before final discharge | Inactivated by validated chemical or physical means | Inactivated by validated chemical or physical means | Inactivated by validated chemical or physical means" |
----------------------
1. Work in food production plants. 2. Work in agriculture. 3. Work activities where there is contact with animals and/or products of animal origin. 4. Work in healthcare, including isolation and post-mortem units. 5. Work in clinical, veterinary and diagnostic laboratories, excluding diagnostic microbiological laboratories. 6. Work in refuse disposal plants. 7. Work in sewage purification installations."
A: Possible allergic effects D: List of workers exposed to this biological agent to be kept for more than 10 years after the end of last known exposure T: Toxin production V: Effective vaccine available and registered within the EU
Biological agent | Classification | Notes |
---|---|---|
W | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | T | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | T, V | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
3 | ||
3 | ||
3 | ||
2 | ||
3 | ||
3 | D | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | T | |
2 | T | |
2 | T | |
2 | T, V | |
2 | ||
2 | T, V | |
2 | ||
2 | T | |
2 | T | |
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | T | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | V | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | V | |
2 | ||
2 | ||
2 | ||
3 | V | |
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | ||
3 | V | |
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | V | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | T | |
2 | ||
3 | ||
3 | ||
3 | ||
2 | ||
3 | ||
3 | ||
3 | ||
2 | ||
3 | ||
3 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | V | |
3 | V | |
2 | ||
2 | ||
2 | ||
3 | T | |
2 | ||
2 | ||
2 | ||
2 | T | |
2 | ||
2 | ||
2 | ||
2 | T, V | |
2 | T | |
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | T, V | |
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 |
Classification | Notes | |
---|---|---|
Bunyavirales (O) | ||
Orthohantavirus (G) | ||
Andes orthohantavirus (Hantavirus species causing Hantavirus Pulmonary Syndrome [HPS]) | 3 | |
Bayou orthohantavirus | 3 | |
Black Creek Canal orthohantavirus | 3 | |
Cano Delgadito orthohantavirus | 3 | |
Choclo orthohantavirus | 3 | |
Dobrava-Belgrade orthohantavirus (Hantavirus species causing Haemorrhagic Fever with Renal Syndrome [HFRS]) | 3 | |
El Moro Canyon orthohantavirus | 3 | |
Hantaan orthohantavirus (Hantavirus species causing Haemorrhagic Fever with Renal Syndrome [HFRS]) | 3 | |
Laguna Negra orthohantavirus | 3 | |
Prospect Hill orthohantavirus | 2 | |
Puumala orthohantavirus (Hantavirus species causing Nephropathia Epidemica [NE]) | 2 | |
Seoul orthohantavirus (Hantavirus species causing Haemorrhagic Fever with Renal Syndrome [HFRS]) | 3 | |
Sin Nombre orthohantavirus (Hantavirus species causing Hantavirus Pulmonary Syndrome [HPS]) | 3 | |
Other hantaviruses known to be pathogenic | 2 | |
Orthonairovirus (G) | ||
Crimean-Congo haemorrhagic fever orthonairovirus | 4 | |
Dugbe orthonairovirus | 2 | |
Hazara orthonairovirus | 2 | |
Nairobi sheep disease orthonairovirus | 2 | |
Other nairoviruses known to be pathogenic | 2 | |
Orthobunyavirus (G) | ||
Bunyamwera orthobunyavirus (Germiston virus) | 2 | |
California encephalitis orthobunyavirus | 2 | |
Oropouche orthobunyavirus | 3 | |
Other orthobunyaviruses known to be pathogenic | 2 | |
Phlebovirus (G) | ||
Bhanja phlebovirus | 2 | |
Punta Toro phlebovirus | 2 | |
Rift Valley fever phl | 3 | |
Sandfly fever Naples phlebovirus (Toscana Virus) | 2 | |
SFTS phlebovirus (Severe Fever with Thrombocytopenia Syndrome-Virus) | 3 | |
Other phleboviruses known to be pathogenic | 2 | |
Herpesvirales (O) | ||
Cytomegalovirus (G) | ||
Human betaherpesvirus 5 (Cytomegalovirus) | 2 | |
Lymphocryptovirus (G) | ||
Human gammaherpesvirus 4 (Epstein-Barr virus) | 2 | |
Rhadinoovirus (G) | ||
Human gammaherpesvirus 8 | 2 | D |
Roseolovirus (G) | ||
Human betaherpesvirus 6A (Human B-lymphotropic virus) | 2 | |
Human betaherpesvirus 6B | 2 | |
Human betaherpesvirus 7 | 2 | |
Simplexvirus (G) | ||
Macacine alphaherpesvirus 1 (Herpesvirus simiae, Herpes B virus) | 3 | |
Human alphaherpesvirus 1 (Human herpesvirus 1, Herpes simplex virus type 1) | 2 | |
Human alphaherpesvirus 2 (Human herpesvirus 2, Herpes simplex virus type 2) | 2 | |
Varicellovirus (G) | ||
Human alphaherpesvirus 3 (Herpesvirus varicella-zoster) | 2 | V |
Mononegavirales (O) | ||
Ebolavirus (G) | 4 | |
Marburgvirus (G) | ||
Marburg marburgvirus | 4 | |
Avulavirus (G) | ||
Newcastle disease virus | 2 | |
Henipavirus (G) | ||
Hendra henipavirus | 4 | |
Nipah henipavirus | 4 | |
Morbillivirus (G) | ||
Measles morbillivirus | 2 | V |
Respirovirus (G) | ||
Human respirovirus 1 (Parainfluenza virus 1) | 2 | |
Human respirovirus 3 (Parainfluenza virus 3) | 2 | |
Rubulavirus (G) | ||
Mumps rubulavirus | 2 | V |
Human rubulavirus 2 (Parainfluenza virus 2) | 2 | |
Human rubulavirus 4 (Parainfluenza virus 4) | 2 | |
Metapneumovirus (G) | ||
Orthopneumovirus (G) | ||
Human orthopneumovirus (Respiratory syncytial virus) | 2 | |
Lyssavirus (G) | ||
Australian bat lyssavirus | 3 | V |
Duvenhage lyssavirus | 3 | V |
European bat lyssavirus 1 | 3 | V |
European bat lyssavirus 2 | 3 | V |
Lagos bat lyssavirus | 3 | |
Mokola lyssavirus | 3 | |
Rabies lyssavirus | 3 | V |
Vesiculovirus (G) | ||
Vesicular stomatitis virus, Alagoas vesiculovirus | 2 | |
Vesicular stomatitis virus, Indiana vesiculovirus | 2 | |
Vesicular stomatitis virus, New Jersey vesiculovirus | 2 | |
Piry vesiculovirus (Piry virus) | 2 | |
Nidovirales (O) | ||
Betacoronavirus (G) | ||
Severe acute respiratory syndrome-related coronavirus (SARS-virus) | 3 | |
Middle East respiratory syndrome coronavirus (MERS-virus) | 3 | |
Other | 2 | |
Picornavirales (O) | ||
Cardiovirus (G) | ||
Saffold virus | 2 | |
Cosavirus (G) | ||
Cosavirus A | 2 | |
Enterovirus (G) | ||
Enterovirus A | 2 | |
Enterovirus B | 2 | |
Enterovirus C | 2 | |
Enterovirus D, Human Enterovirus type 70 (Acute haemorrhagic conjunctivitis virus) | 2 | |
Rhinoviruses | 2 | |
Poliovirus, type 1 and 3 | 2 | V |
Poliovirus, type 2 | 3 | V |
Hepatovirus (G) | ||
Hepatovirus A (Hepatitis A virus, Human Enterovirus type 72) | 2 | V |
Kobuvirus (G) | ||
Aichivirus A (Aichi virus 1) | 2 | |
Parechovirus (G) | ||
Parechoviruses A | 2 | |
Parechoviruses B (Ljungan virus) | 2 | |
Other | 2 | |
Unassigned (O) | ||
2 | ||
2 | ||
Mammarenavirus (G) | ||
Brazilian mammarenavirus | 4 | |
Chapare mammarenavirus | 4 | |
Flexal mammarenavirus | 3 | |
Guanarito mammarenavirus | 4 | |
Junín mammarenavirus | 4 | |
Lassa mammarenavirus | 4 | |
Lujo mammarenavirus | 4 | |
Lymphocytic choriomeningitis mammarenavirus, neurotropic strains | 2 | |
Lymphocytic choriomeningitis mammarenavirus (other strains) | 2 | |
Machupo mammarenavirus | 4 | |
Mobala mammarenavirus | 2 | |
Mopeia mammarenavirus | 2 | |
Tacaribe mammarenavirus | 2 | |
Whitewater Arroyo mammarenavirus | 3 | |
Norovirus (G) | ||
Norovirus (Norwalk virus) | 2 | |
Other | 2 | |
Orthohepadnavirus (G) | ||
Hepatitis B virus | 3 | V, D |
Orthohepevirus (G) | ||
Orthohepevirus A (Hepatitis E virus) | 2 | |
Flavivirus (G) | ||
Dengue virus | 3 | |
Japanese encephalitis virus | 3 | V |
Kyasanur Forest disease virus | 3 | V |
Louping ill virus | 3 | |
Murray Valley encephalitis virus (Australia encephalitis virus) | 3 | |
Omsk haemorrhagic fever virus | 3 | |
Powassan virus | 3 | |
Rocio virus | 3 | |
St. Louis encephalitis virus | 3 | |
Tick-borne encephalitis virus | ||
Absettarov virus | 3 | |
Hanzalova virus | 3 | |
Hypr virus | 3 | |
Kumlinge virus | 3 | |
Negishi virus | 3 | |
Russian spring-summer encephalitis | 3 | V |
Tick-borne encephalitis virus Central European subtype | 3 | V |
Tick-borne encephalitis virus Far Eastern Subtype | 3 | |
Tick-borne encephalitis virus Siberian subtype | 3 | V |
Wesselsbron virus | 3 | |
West Nile fever virus | 3 | |
Yellow fever virus | 3 | V |
Zika virus | 2 | |
Other flaviviruses known to be pathogenic | 2 | |
Hepacivirus (G) | ||
Hepacivirus C (Hepatitis C virus) | 3 | D |
Gammainfluenzavirus (G) | ||
Influenza C virus | 2 | V |
Influenzavirus A (G) | ||
Highly Pathogenic Avian Influenza Viruses HPAIV (H5), e.g. H5N1 | 3 | |
Highly Pathogenic Avian Influenza Viruses HPAIV (H7), e.g. H7N7, H7N9 | 3 | |
Influenza A virus | 2 | V |
Influenza A virus A/New York/1/18 (H1N1) (Spanish flu 1918) | 3 | |
Influenza A virus A/Singapore/1/57 (H2N2) | 3 | |
Low Pathogenic Avian Influenza Virus (LPAI) H7N9 | 3 | |
Influenzavirus B (G) | ||
Influenza B virus | 2 | V |
Thogoto virus (G) | ||
Dhori virus (Tick-borne | 2 | |
Thogoto virus (Tick-borne | 2 | |
2 | D | |
Erythroparvovirus (G) | ||
Primate erythroparvovirus 1 (Human parvovirus, B 19 virus) | 2 | |
Betapolyomavirus (G) | ||
Human polyomavirus 1 (BK virus) | 2 | D |
Human polyomavirus 2 (JC virus) | 2 | D |
Molluscipoxvirus (G) | ||
Molluscum contagiosum virus | 2 | |
Orthopoxvirus (G) | ||
Cowpox virus | 2 | |
Monkeypox virus | 3 | V |
Vaccinia virus (incl. Buffalopox virus | 2 | |
Variola (major and minor) virus | 4 | V |
Parapoxvirus (G) | ||
Orf virus | 2 | |
Pseudocowpox virus (Milkers’ node virus, parapoxvirus bovis) | 2 | |
Yatapoxvirus (G) | ||
Tanapox virus | 2 | |
Yaba monkey tumor virus | 2 | |
Seadornavirus (G) | ||
Banna virus | 2 | |
Coltivirus (G) | 2 | |
Rotavirus | 2 | |
Orbivirus (G) | 2 | |
Deltaretrovirus (G) | ||
Primate T-lymphotropic virus 1 (Human T-cell lymphotropic virus, type 1) | 3 | D |
Primate T-lymphotropic virus 2 (Human T-cell lymphotropic virus, type 2) | 3 | D |
Lentivirus (G) | ||
Human immunodeficiency virus 1 | 3 | D |
Human immunodeficiency virus 2 | 3 | D |
Simian Immunodeficiency Virus (SIV) | 2 | |
Alphavirus (G) | ||
Cabassouvirus | 3 | |
Eastern equine encephalomyelitis virus | 3 | V |
Bebaru virus | 2 | |
Chikungunya virus | 3 | |
Everglades virus | 3 | |
Mayaro virus | 3 | |
Mucambo virus | 3 | |
Ndumu virus | 3 | |
O’nyong-nyong virus | 2 | |
Ross River virus | 2 | |
Semliki Forest virus | 2 | |
Sindbis virus | 2 | |
Tonate virus | 3 | |
Venezuelan equine encephalomyelitis virus | 3 | V |
Western equine encephalomyelitis virus | 3 | V |
Other alphaviruses known to be pathogenic | 2 | |
Rubivirus (G) | ||
Rubella virus | 2 | V |
Deltavirus (G) | ||
Hepatitis delta virus | 2 | V, D |
Biological agent | Classification | Notes |
---|---|---|
Agent of Creutzfeldt-Jakob disease | 3 | D |
Variant Agent of Creutzfeldt-Jakob disease | 3 | D |
Agent of Bovine Spongiform Encephalopathy (BSE) and other related animal TSEs | 3 | D |
Agent of Gerstmann-Sträussler-Scheinker syndrome | 3 | D |
Agent of Kuru | 3 | D |
Agent of Scrapie | 2 |
Biological agent | Classification | Notes |
---|---|---|
2 | ||
2 | ||
2 | ||
2 | ||
2 | A | |
2 | A | |
2 | A | |
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
3 | ||
3 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
2 |
Biological agent | Classification | Notes |
---|---|---|
2 | A | |
2 | A | |
2 | ||
3 | ||
3 | ||
2 | A | |
2 | ||
2 | ||
2 | ||
2 | ||
3 | ||
3 | ||
2 | ||
3 | A | |
3 | A | |
2 | A | |
2 | A | |
2 | ||
2 | ||
2 | A | |
2 | ||
2 | ||
3 | ||
3 | ||
3 | ||
2 | ||
2 | ||
2 | A | |
2 | ||
2 | ||
3 | A | |
3 | ||
2 | ||
3 | ||
2 | ||
2 | ||
2 | ||
2 | A | |
2 | A | |
2 | A | |
2" |
----------------------
A. Containment measures | B. Containment levels | ||
---|---|---|---|
2 | 3 | 4 | |
Workplace | |||
1. The workplace is to be separated from any other activities in the same building | No | Recommended | Yes |
2. The workplace is to be sealable to permit fumigation | No | Recommended | Yes |
Facilities | |||
3. Infected material including any animal is to be handled in a safety cabinet or isolation or other suitable containment | Where appropriate | Yes, where infection is by airborne route | Yes |
Equipment | |||
4. Input air and extract air to the workplace are to be filtered using (HEPA | No | Yes, on extract air | Yes, on input and extract air |
5. The workplace is to be maintained at an air pressure negative to atmosphere | No | Recommended | Yes |
6. Surfaces impervious to water and easy to clean | Yes, for bench and floor | Yes, for bench, floor and other surfaces determined by risk assessment | Yes, for bench, walls, floor and ceiling |
7. Surfaces resistant to acids, alkalis, solvents, disinfectants | Recommended | Yes | Yes |
System of work | |||
8. Access is to be restricted to nominated workers only | Recommended | Yes | Yes, via airlock |
9. Efficient vector control, for example rodents and insects | Recommended | Yes | Yes |
10. Specified disinfection procedures | Yes | Yes | Yes |
11. Safe storage of a biological agent | Yes | Yes | Yes, secure storage |
12. Personnel should shower before leaving the contained area | No | Recommended | Recommended |
Waste | |||
13. Validated inactivation process for the safe disposal of animal carcases | Recommended | Yes, on or off site | Yes, on site |
Other measures | |||
14. A laboratory is to contain its own equipment | No | Recommended | Yes |
15. An observation window, or, alternative, is to be present, so that occupants can be seen | Recommended | Recommended | Yes" |
----------------------
A. Containment measures | B. Containment levels | ||
---|---|---|---|
2 | 3 | 4 | |
General | |||
1. Viable organisms should be handled in a system which physically separates the process from the environment | Yes | Yes | Yes |
2. Exhaust gases from the closed system should be treated so as to: | Minimise release | Prevent release | Prevent release |
3. Sample collection, addition of materials to a closed system and transfer of viable organisms to another closed system, should be performed so as to: | Minimise release | Prevent release | Prevent release |
4. Bulk culture fluids should not be removed from the closed system unless the viable organisms have been: | Inactivated by validated chemical or physical means | Inactivated by validated chemical or physical means | Inactivated by validated chemical or physical means |
5. Seals should be designed so as to: | Minimise release | Prevent release | Prevent release |
6. The controlled area should be designed to contain spillage of the entire contents of the closed system | No | Recommended | Yes |
7. The controlled area should be sealable to permit fumigation | No | Recommended | Yes |
Facilities | |||
8. Decontamination and washing facilities should be provided for personnel | Yes | Yes | Yes |
Equipment | |||
9. Input air and extract air to the controlled area should be HEPA | No | Recommended | Yes |
10. The controlled area should be maintained at an air pressure negative to atmosphere | No | Recommended | Yes |
11. The controlled area should be adequately ventilated to minimise air contamination | Recommended | Recommended | Yes |
System of work | |||
12. Closed systems | Recommended | Recommended | Yes, and purpose-built |
13. Biohazard signs should be posted | Recommended | Yes | Yes |
14. Access should be restricted to nominated personnel only | Recommended | Yes | Yes, via an airlock |
15. Personnel should shower before leaving the controlled area | No | Recommended | Yes |
16. Personnel should wear protective clothing | Yes, work clothing | Yes | Yes, complete change |
Waste | |||
17. Effluent from sinks and showers should be collected and inactivated before release | No | Recommended | Yes |
18. Effluent treatment before final discharge | Inactivated by validated chemical or physical means | Inactivated by validated chemical or physical means | Inactivated by validated chemical or physical means" |
----------------------